Back
Keros Therapeutics Stock Price Chart
Sponsored
KROS
Sponsored
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]
Sell
10
KROS
Keros Therapeutics
Last Price:
$11.43
Seasonality Move:
-1.63%
7 Day Trial
ALL ACCESS PASS
$
7
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.
Keros Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.25 | Sell |
20-day SMA: | 14.7 | Sell |
50-day SMA: | 38.51 | Sell |
200-day SMA: | 49.19 | Sell |
8-day EMA: | 12.27 | Sell |
20-day EMA: | 17.76 | Sell |
50-day EMA: | 31.45 | Sell |
200-day EMA: | 45.72 | Sell |
Keros Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -7.43 | Sell |
Relative Strength Index (14 RSI): | 22.44 | Sell |
Chaikin Money Flow: | 854416 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.88 - 17.98) | Sell |
Bollinger Bands (100): | (28.46 - 66.92) | Sell |
Keros Therapeutics Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Keros Therapeutics Stock
Is Keros Therapeutics Stock a Buy?
-
Keros Therapeutics share price is 11.41 while KROS 8-day simple moving average is 12.25, which is a Sell signal.
-
The stock price of KROS is 11.41 while Keros Therapeutics 20-day SMA is 14.70, which makes it a Sell.
-
Keros Therapeutics 50-day simple moving average is 38.51 while KROS share price is 11.41, making it a Sell technically.
-
KROS stock price is 11.41 and Keros Therapeutics 200-day simple moving average is 49.19, creating a Sell signal.
KROS Technical Analysis vs Fundamental Analysis
Sell
10
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy or a Sell?
-
Keros Therapeutics stock is rated a SellThe current Keros Therapeutics [KROS] share price is $11.41. The Score for KROS is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
Keros Therapeutics Stock Info
Market Cap:
462.2M
Price in USD:
11.41
Share Volume:
2.9M
Keros Therapeutics 52-Week Range
52-Week High:
73.00
52-Week Low:
9.78
Sell
10
Keros Therapeutics (KROS)
is a Sell
Keros Therapeutics Share Price Forecast
-
What is the Keros Therapeutics stock price today?The Keros Therapeutics stock price is 11.41 USD today.
-
Will KROS stock go up or go down?Keros Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Keros Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics is overvalued.
Is Keros Therapeutics Stock a Buy?
-
Keros Therapeutics share price is 11.41 while KROS 8-day exponential moving average is 12.27, which is a Sell signal.
-
The stock price of KROS is 11.41 while Keros Therapeutics 20-day EMA is 17.76, which makes it a Sell.
-
Keros Therapeutics 50-day exponential moving average is 31.45 while KROS share price is 11.41, making it a Sell technically.
-
KROS stock price is 11.41 and Keros Therapeutics 200-day simple moving average is 45.72, creating a Sell signal.
Fundamental Analysis of Keros Therapeutics
Is Keros Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and a decrease next year of $0.67 per share.
Technical Analysis of Keros Therapeutics
Should I short Keros Therapeutics stock?
-
KROS Moving Average Covergence Divergence (MACD) indicator is -7.43, suggesting Keros Therapeutics is a Sell
-
Keros Therapeutics Relative Strength Index (RSI) is 22.44, which suggest Keros Therapeutics is oversold
-
The Bollinger Bands (25) for Keros Therapeutics is (12.88 - 17.98), which suggest Keros Therapeutics is a Sell
-
The Bollinger Bands (100) for Keros Therapeutics is (28.46 - 66.92), which suggest Keros Therapeutics is a Sell
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.